Document ID: chunk:federal_register_of_legislation:C2024C00632:section:30:p1
Version: federal_register_of_legislation:C2024C00632
Segment Type: section
Provision Reference: s 30 (pt 1/4)
Character Range: 315269–317967

30  Cancellation of registration or listing
 (1) The Secretary may, by notice in writing given to a person in relation to whom therapeutic goods are included in the Register, cancel the registration or listing of the goods if:
 (a) it appears to the Secretary that failure to cancel the registration or listing would create an imminent risk of death, serious illness or serious injury; or
 (b) the goods become exempt goods; or
 (c) the person requests in writing the cancellation of the registration or listing; or
 (d) the goods contain substances that are prohibited imports for the purposes of the Customs Act 1901; or
 (da) the person has refused or failed to comply with the condition to which the inclusion of the goods is subject under paragraph 28(5)(d):
 (i) if the person was requested under that paragraph to make the record in question available at or before a requested time—before the end of the period of 24 hours after that time; or
 (ii) if the person was requested under that paragraph to make the record in question available immediately—within 24 hours after the request was made; or
 (e) in the case of a medicine listed under section 26A, it appears to the Secretary that any of the certifications under paragraph 26A(2)(a), (ca), (cb), (e), (fba), (fd), (fe) or (g) are incorrect or (if applicable) the requirements under subsection 26A(3) or (4A) are not fulfilled; or
 (ea) in the case of a medicine listed under section 26AE, it appears to the Secretary that any of the certifications under paragraph 26AB(2)(a), (d), (e), (h) or (n) are incorrect or (if applicable) the requirements under subsection 26AB(4) or (6) are not fulfilled; or
 (f) the person contravenes a direction, or a condition of a direction, given to the person under subsection 42DV(1) or 42DZK(1) in relation to the advertising of the goods and the Secretary is satisfied that the contravention is significant; or
 (fa) if the person is a body corporate—a related body corporate of the person contravenes a direction, or a condition of a direction, given to the related body corporate under subsection 42DV(1) or 42DZK(1) in relation to the advertising of the goods and the Secretary is satisfied that the contravention is significant; or
 (fb) there is a breach, involving the goods, of an applicable provision of the Therapeutic Goods Advertising Code or any other requirement relating to advertising applicable under Part 5‑1 or 5‑1A or under the regulations, and the Secretary is satisfied that:
 (i) the breach is significant; and
 (ii) as a result of the breach, the presentation of the goods is misleading to a significant extent; or
 (g) the Secretary is satisfied that a statement made in, or